About Center for Cancer Therapy at LaPorte Hospital and Health Services
Clinical Trials at Center for Cancer Therapy at LaPorte Hospital and Health Services
During the past decade, Center for Cancer Therapy at LaPorte Hospital and Health Services conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 79 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 14 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Center for Cancer Therapy at LaPorte Hospital and Health Services" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 66 trials, followed by "Eastern Cooperative Oncology Group" with 20 trials
sponsored, "Radiation Therapy Oncology Group" with 10 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored and "NSABP Foundation Inc"
with 9 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Cancer Therapy at LaPorte Hospital and Health Services"
#1 collaborator was "National Cancer Institute (NCI)" with 126 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator and "Eastern Cooperative Oncology Group" with 6 trials as a collaborator. Other collaborators include 26 different institutions and companies that were
collaborators in the rest 23 trials.
Clinical Trials Conditions at Center for Cancer Therapy at LaPorte Hospital and Health Services
According to Clinical.Site data, the most researched conditions in "Center for Cancer Therapy at LaPorte Hospital and Health Services" are
"Breast Cancer" (36 trials), "Lung Cancer" (19 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Lymphoma" (11 trials) and "Colorectal Cancer" (10 trials). Many other conditions were trialed in "Center for Cancer Therapy at LaPorte Hospital and Health Services" in a lesser frequency.
Clinical Trials Intervention Types at Center for Cancer Therapy at LaPorte Hospital and Health Services
Most popular intervention types in "Center for Cancer Therapy at LaPorte Hospital and Health Services" are "Drug" (98 trials), "Other" (39 trials), "Biological" (32 trials), "Radiation" (26 trials) and "Procedure" (18 trials). Other intervention types were less common.
The name of intervention was led by "placebo" (27 trials), "radiation therapy" (14 trials), "cisplatin" (13 trials), "carboplatin" (12 trials) and "gemcitabine hydrochloride" (11 trials). Other intervention names were less common.
Clinical Trials Genders at Center for Cancer Therapy at LaPorte Hospital and Health Services
The vast majority of trials in "Center for Cancer Therapy at LaPorte Hospital and Health Services" are
93 trials for "All" genders, 29 trials for "Female" genders and 6 trials for "Male" genders.
Clinical Trials Status at Center for Cancer Therapy at LaPorte Hospital and Health Services
Currently, there are NaN active trials in "Center for Cancer Therapy at LaPorte Hospital and Health Services".
undefined are not yet recruiting,
undefined are recruiting,
13 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 103 completed trials in Center for Cancer Therapy at LaPorte Hospital and Health Services,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Center for Cancer Therapy at LaPorte Hospital and Health Services, 2 "Phase 1"
clinical trials were conducted, 50 "Phase 2" clinical
trials and 61 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".